SAN FRANCISCO, May 14, 2025 (GLOBE NEWSWIRE) — Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation…Read More
You might also be interested in reading Dogecoin whales go silent — and traders wonder if the bark has any bite left.